← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2005Last known activity
Sep 30, 2020
Timeline
1980s
- Jan 1, 1988
Mateon Therapeutics— Founded
Drugs by trial phase (11 distinct, 15 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Studied for
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Choroidal Neovascularization
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Neoplasms
- Myelodysplastic Syndromes
- Myopia
- Myopia, Degenerative
- Neoplasm Metastasis
- Neoplasms
- Neovascularization, Pathologic
- Neuroendocrine Tumors
- Ovarian Neoplasms
- Thyroid Carcinoma, Anaplastic
- Thyroid Diseases
- Thyroid Neoplasms
- Vascular Diseases
Recent trials (17)
- NCT05004753Lead sponsorPhase 4Sep 30, 2020
- NCT02641639Lead sponsorPhase 2/Phase 3Jun 1, 2016
- NCT02576301Lead sponsorPhase 1/Phase 2Oct 1, 2015
- NCT01701349Lead sponsorPhase 3Mar 1, 2015
- NCT02279602Lead sponsorPhase 2Dec 1, 2014
- NCT02055690CollaboratorPhase 1/Phase 2Sep 1, 2014
- NCT02132468Lead sponsorPhase 2Sep 1, 2014
- NCT00960557Lead sponsorPhase 1Jul 1, 2009
- NCT01023295Lead sponsorPhase 2Jul 1, 2009
- NCT00653939Study directorPhase 2Mar 1, 2008
- NCT00653939Lead sponsorPhase 2Mar 1, 2008
- NCT00507429Lead sponsorPhase 2/Phase 3Aug 1, 2007
- NCT00395434Study directorPhase 1Sep 1, 2006
- NCT00395434Lead sponsorPhase 1Sep 1, 2006
- NCT00977210Lead sponsorPhase 1Jul 1, 2005
Details
- Founded
- South San Francisco, CA, US Jan 1, 1988
- Last known activity
- Sep 30, 2020
Notes
--- Pre-folding founded info: 1988-06-01 South San Francisco CA US https://www.crunchbase.com/organization/oxigene#section-overview ---